Author:
Legrand Matthieu,Bagshaw Sean M.,Bhatraju Pavan K.,Bihorac Azra,Caniglia Ellen,Khanna Ashish K.,Kellum John A.,Koyner Jay,Harhay Michael O.,Zampieri Fernando G.,Zarbock Alexander,Chung Kevin,Liu Kathleen,Mehta Ravindra,Pickkers Peter,Ryan Abigail,Bernholz Juliane,Dember Laura,Gallagher Martin,Rossignol Patrick,Ostermann Marlies
Abstract
AbstractAcute kidney injury (AKI) often complicates sepsis and is associated with high morbidity and mortality. In recent years, several important clinical trials have improved our understanding of sepsis-associated AKI (SA-AKI) and impacted clinical care. Advances in sub-phenotyping of sepsis and AKI and clinical trial design offer unprecedented opportunities to fill gaps in knowledge and generate better evidence for improving the outcome of critically ill patients with SA-AKI. In this manuscript, we review the recent literature of clinical trials in sepsis with focus on studies that explore SA-AKI as a primary or secondary outcome. We discuss lessons learned and potential opportunities to improve the design of clinical trials and generate actionable evidence in future research. We specifically discuss the role of enrichment strategies to target populations that are most likely to derive benefit and the importance of patient-centered clinical trial endpoints and appropriate trial designs with the aim to provide guidance in designing future trials.
Publisher
Springer Science and Business Media LLC
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献